Your session is about to expire
← Back to Search
Other
High-Flow Nasal Cannula for Cardiac Surgery
N/A
Recruiting
Led By Robert E Freundlich, MD
Research Sponsored by Vanderbilt University Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Must not have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up72 hours
Awards & highlights
No Placebo-Only Group
Study Summary
This trial will compare the reintubation rates and outcomes of patients treated with high-flow nasal cannula oxygen therapy versus those treated with standard care.
Eligible Conditions
- Intubation
- Cardiac Surgery
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 72 hours
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~72 hours
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Reintubation within 48 hours of extubation
Secondary outcome measures
Perinatal death
Hospital length of stay
In-hospital mortality
+4 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: High Flow Nasal Canula Oxygen TherapyExperimental Treatment1 Intervention
Participants will be assigned post extubation physician order set which recommends the administration of oxygen therapy via HFNC. HFNC is a heated and humidified system that allows prescribed fraction of inspired oxygen (FIO2) levels to be delivered at very high flow rates.
Group II: Provider Choice Standard CareActive Control1 Intervention
Participants be assigned standard provider choice of standard care therapy physician order set.
Find a Location
Who is running the clinical trial?
Vanderbilt University Medical CenterLead Sponsor
832 Previous Clinical Trials
654,526 Total Patients Enrolled
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,766 Previous Clinical Trials
47,260,284 Total Patients Enrolled
Robert E Freundlich, MDPrincipal InvestigatorVanderbilt University Medical Center
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:Research Study Groups:
This trial has the following groups:- Group 1: Provider Choice Standard Care
- Group 2: High Flow Nasal Canula Oxygen Therapy
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What is the capacity of enrollees for this research endeavor?
"Yes, the information on clinicaltrials.gov attests to this research being actively looking for participants. It was published on November 1st 2021 and most recently updated on November 2nd 2022; 3192 subjects are needed at a single medical facility."
Answered by AI
Are applications for this research program currently being accepted?
"Affirmative. Evidenced by clinicaltrials.gov, this medical trial is presently looking for participants. It was first advertised on November 1st 2021 and has been recently updated on November 2nd 2022; the aim being to recruit 3192 individuals from a single clinic."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger